top of page

SPPI

Spectrum Pharmaceuticals

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$89.2M

Burn Rate (Qtr)

$30.3M

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

SPPI

BPIQ_Logo_RGB-01.jpg

Company Profile

Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncology and Hematology. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy.

Recent Posts

See what the community is saying - click to see full post.

November 2022 Big Mover™ Stocks and Movers to Watch Report

Biotech PDUFAs to Watch November 2022 - PRVB, SPPI, YMAB

Results from Twitter Polls

Amp Funds & Q2 '22 Hedge Fund Analysis

ESMO 2022 Investor Hub

ESMO 2022 Investor Hub

bottom of page